ABOS
ABOS
NASDAQ · Biotechnology

Acumen Pharmaceuticals Inc

$0.21
0.00 (-1.83%)
As of Nov 15, 10:41 PM ET ·
Analyst Consensus
Strong Sell
11
Analysts
Moderate
Coverage
Buy 2 18%
Hold 4 36%
Sell 5 45%
Price Target
Analyst Price Target +10,283.2% upside
Low Target $18.81
Average Target $22.22
High Target $35.10
Current Price $0.21
Current
$0.21
Target
$22.22
$18.81 $22.22 avg $35.10
Scenario Analysis
Bear Case
$18.81
8,689.7%
Low target
Base Case
$22.22
+10,283.2%
Avg target
Bull Case
$35.10
+16,301.9%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$3.60
-94.1% from high
52-Week Low
$0.19
+12.0% from low
50-Day SMA
$1.90
-88.7% vs SMA
RSI (14)
17.2
Oversold
Target vs 52W High
$22.22
+517.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.7%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -18.6%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -92.0%
MRNA
Moderna Inc
Hold 31 32% $149.45 -33.1%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.2%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -33.8%